On November 8 of 2019, JAMA—Journal of the American Medical Association published “Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes” (doi:10.1001/jama.2019.17380). In this study review, by Dr. Alex Vasquez, he outlines the poor design of the study and the “misrepresentationRead
Glucosamine is a popular non-vitamin, non-mineral supplement widely used for osteoarthritis and joint pain. While the effectiveness of glucosamine in patients with osteoarthritis and joint pain is well known, emerging evidence from epidemiological studies suggests that glucosamine could have a role in preventing cardiovascular disease (CVD) and reducing mortality. A previousRead
Research in past decade shows that iron, from food and supplementation, may increase the risk of premature age-related macular degeneration. A recent study, published in Retina, outlines the importance of discussing this risk for patients who may be taking iron unknowingly – in a multi-vitamin or by self-indication – andRead
The recently established test, which is the first of its kind in the industry, is able to verify both ingredients and end- consumer products, including concentrated fish oil. The testing technology is based on proven NMR analysis combined with a strong database of known reference samples and powerful analysis algorithms.Read
Postnatal supplementation with micronutrients could play a role in countering the negative effects of early life stress (ES) for infants. The significance of this recent study shows that when lactating mothers receive adequate essential miconutrients their children are less likely to suffer from cognitive problems later in life as aRead
Can you really get everything you need in your diet? Perhaps even more important, are your patients getting everything they need in theirs? In this webinar and interview, Dr Tieraona Low Dog gives practitioners a preview of her upcoming book, Fortify Your Life with National Geographic (Feb. 2016). She makesRead
The use of dietary supplements among patients affected by cancer is extensive, with an estimated 20-90 % of patients using these products. Their use of these products is often not shared with the treating physician. “Doctors need to understand why patients with cancer use dietary supplements in the first place. Patients tend to use these supplements because they want to do everything possible to feel hopeful, empower themselves, enhance the body’s natural defenses, use less toxic treatments, or reduce side effects of mainstream treatments,” said Dr. Victor Sierpina, UTMB professor of family medicine. “In fact, most patients choose to use dietary supplements to improve their quality of life rather than seeking a cure for their disease.” In the September issue of Current Oncology Reports, researchers at University of Texas Medical Branch, Sierpina describes a patient centered approach to managing dietary supplement use in cancer care. By Moshe Frenkel and Victor Sierpina, published in Current Oncology, Sept. 2014.
It is well known among researchers that mitochondrial genetic or primary mitochondrial disorders contribute to mitochondrial dysfunction as well as secondary or acquired degenerative disorders. This review will concentrate on nongenetic or acquired mechanisms that could explain mitochondrial dysfunction and their replacement treatment with natural supplements and combinations of natural supplements, including vitamins, minerals, enzyme cofactors, antioxidants, metabolites, transporters, membrane-type phospholipids, and other natural supplements. Combinations of supplements can reduce significantly the fatigue and other symptoms associated with chronic disease and can naturally restore mitochondrial function, even in long-term patients with intractable fatigue. By Garth Nicholsen, PhD, published in Alternative Therapies Health Med. 2014, Vol. 20, Suppl. 1.
This study was a pilot study to assess the effect of perioperatively administering oral cystine and theanine in gastric surgery patients and suggested that oral administration of these amino acids may reduce inflammation and promote recovery after gastric surgery. This study postulated that cystine and theanine would reduce excessive inflammation and immune suppression during the perioperative periods of abdominal surgeries, which decreases GSH levels in blood and skeletal muscle. The researchers examined the effects of perioperatively administering cystine and theanine on the postoperative course of gastric cancer patients undergoing distal gastrectomies as a pilot study. By Tomohiro Miyachi MD, Takashi Tsuchiya, MD et al., published in J of Parenteral and Enteral Nutrition, 2012.
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
